CASPIAN Proves Too Choppy For AZ Imfinzi/Tremelimumab Combo

But Imfinzi Benefit Reinforced For Small Cell Lung Cancer

 
• By Kevin Grogan

Another day and another fail for AstraZeneca's combination of Imfinzi and tremelimumab, this time for extensive-stage small-cell lung cancer.

Baku_City
CASPIAN not so serene for tremelimumab • Source: Shutterstock

More from Clinical Trials

More from R&D